Incidence and Risk Factors for Metabolic Bone Disease of Prematurity in Indian Infants: A Prospective Observational

S B Mithun Krishna1, Jitendra Meena2, Jogender Kumar3

  • 1Neonatal Unit, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.

Indian Pediatrics
|April 3, 2025
PubMed

Insights

Nearly 40% of preterm infants experienced moderate-to-severe metabolic bone disease of prematurity (MBDP). Lower birth weight was a significant risk factor for severe MBDP in this cohort.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Nutritional Science

Background:

  • Metabolic bone disease of prematurity (MBDP) is a significant concern in extremely preterm infants.
  • Early identification and management are crucial to prevent long-term skeletal complications.

Purpose of the Study:

  • To determine the incidence of moderate-to-severe MBDP in preterm infants.
  • To identify risk factors associated with MBDP in this vulnerable population.

Main Methods:

  • Serum calcium, phosphorus, and alkaline phosphatase levels were used to screen infants born at ≤ 33 weeks' gestation.
  • Screening occurred from 3-6 weeks of age, repeated as needed up to three months corrected age.
  • Infant feeding, nutrient supplementation, and morbidity data were analyzed and compared between infants with and without MBDP.

Main Results:

  • The study included 153 preterm infants.
  • A total of 22 infants (14.4%) had moderate MBDP, and 28 infants (18.3%) had severe MBDP.
  • Lower birth weight was found to be an independent risk factor for severe MBDP (P=0.009).

Conclusions:

  • Approximately 40% of the preterm infants in the study cohort presented with moderate-to-severe MBDP.
  • Lower birth weight is a key predictor for developing severe MBDP.
  • These findings highlight the high prevalence of MBDP and the need for targeted interventions in preterm infants.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
115
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
600
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.5K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K